Determinants of Response at 2 Months of Treatment in a Cohort of Pakistani Patients with Pulmonary Tuberculosis
Mycobacterium tuberculosis infection continues to be a major global challenge. All patients with pulmonary tuberculosis are treated with a standard 6-month treatment regimen. Historical data suggest that even with shortened treatment, most patients achieve long-term remission. Risk stratification is...
Main Authors: | Saeed Shah, Asghar Khan, Muhammad Shahzad, Jawahir A. Mokhtar, Steve Harakeh, Zeeshan Kibria, Aneela Mehr, Bushra Bano, Asif Ali, Yasar Mehmood Yousafzai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/10/1307 |
Similar Items
-
Clinical forms and outcome of tuberculosis in HIV-infected patients in a tertiary hospital in São Paulo - Brazil
by: Giselle Burlamaqui Klautau, et al. -
Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers
by: Stefan H.E. Kaufmann, et al.
Published: (2017-08-01) -
Recurrence Rate of Pulmonary Tuberculosis in Patients Treated with the Standard 6-Month Regimen: Findings and Implications from a Prospective Observational Multicenter Study
by: Mohammed Saif Anaam, et al.
Published: (2023-02-01) -
Genitourinary Tuberculosis: A Comprehensive Review of a Neglected Manifestation in Low-Endemic Countries
by: Guglielmo Mantica, et al.
Published: (2021-11-01) -
Tuberculosis in Adolescents in Bulgaria for a Three-Year Period: 2018–2020
by: Natalia Gabrovska, et al.
Published: (2022-05-01)